OrthoPediatrics Corp Cost of Revenue
OrthoPediatrics Corp (KIDS) reported Cost of Revenue of $18.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-05
- OrthoPediatrics Corp cost of goods and services sold for the quarter ending 2026-06-30 was $18.14M, a 6.32% increase year-over-year.
- OrthoPediatrics Corp cost of goods and services sold for the quarter ending 2026-03-31 was $15.97M, a 12.88% increase year-over-year.
- OrthoPediatrics Corp cost of goods and services sold for the quarter ending 2025-12-31 was $16.50M, a 3.53% decline year-over-year.
- OrthoPediatrics Corp cost of goods and services sold for the quarter ending 2025-09-30 was $15.98M, a 10.08% increase year-over-year.
- OrthoPediatrics Corp cost of goods and services sold for fiscal 2025 was $63.69M, a 13.47% increase from fiscal 2024.
- OrthoPediatrics Corp cost of goods and services sold for fiscal 2024 was $56.13M, a 49.76% increase from fiscal 2023.
- OrthoPediatrics Corp cost of goods and services sold for fiscal 2023 was $37.48M, a 18.50% increase from fiscal 2022.
- OrthoPediatrics Corp cost of goods and services sold for fiscal 2022 was $31.63M, a 28.33% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.14M 10-Q · filed 2026-08-05 | $34.11M 10-Q · filed 2026-08-05 | $50.61M derived: sum of 3 quarters · filed 2026-08-05 | $66.59M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $15.97M 10-Q · filed 2026-05-01 | $32.47M derived: sum of 2 quarters · filed 2026-05-01 | $48.45M derived: sum of 3 quarters · filed 2026-05-01 | $65.51M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $32.48M derived: sum of 2 quarters · filed 2026-03-04 | $49.54M derived: sum of 3 quarters · filed 2026-08-05 | $63.69M 10-K · filed 2026-03-04 |
| 2025-09-30 | $15.98M 10-Q · filed 2025-10-29 | $33.04M derived: sum of 2 quarters · filed 2026-08-05 | $47.19M 10-Q · filed 2025-10-29 | $64.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $17.06M 10-Q · filed 2026-08-05 | $31.21M 10-Q · filed 2026-08-05 | $48.31M derived: sum of 3 quarters · filed 2026-08-05 | $62.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $14.15M 10-Q · filed 2026-05-01 | $31.25M derived: sum of 2 quarters · filed 2026-05-01 | $45.76M derived: sum of 3 quarters · filed 2026-05-01 | $57.77M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $31.61M derived: sum of 2 quarters · filed 2026-03-04 | $43.62M derived: sum of 3 quarters · filed 2026-03-04 | $56.13M 10-K · filed 2026-03-04 |
| 2024-09-30 | $14.51M 10-Q · filed 2025-10-29 | $26.52M derived: sum of 2 quarters · filed 2025-10-29 | $39.03M 10-Q · filed 2025-10-29 | $49.93M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | $12.00M 10-Q · filed 2025-08-06 | $24.51M 10-Q · filed 2025-08-06 | $35.41M derived: sum of 3 quarters · filed 2026-03-04 | $44.43M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $12.51M 10-Q · filed 2025-05-08 | $23.41M derived: sum of 2 quarters · filed 2026-03-04 | $32.43M derived: sum of 3 quarters · filed 2026-03-04 | $41.96M derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $19.92M derived: sum of 2 quarters · filed 2026-03-04 | $29.45M derived: sum of 3 quarters · filed 2026-03-04 | $37.48M 10-K · filed 2026-03-04 |
| 2023-09-30 | $9.02M 10-Q · filed 2024-11-07 | $18.55M derived: sum of 2 quarters · filed 2024-11-07 | $26.58M 10-Q · filed 2024-11-07 | $36.35M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $9.53M 10-Q · filed 2024-08-06 | $17.56M 10-Q · filed 2024-08-06 | $27.33M derived: sum of 3 quarters · filed 2025-03-05 | $36.39M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $8.03M 10-Q · filed 2024-05-07 | $17.80M derived: sum of 2 quarters · filed 2025-03-05 | $26.86M derived: sum of 3 quarters · filed 2025-03-05 | $34.80M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $9.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $18.83M derived: sum of 2 quarters · filed 2025-03-05 | $26.78M derived: sum of 3 quarters · filed 2025-03-05 | $31.63M 10-K · filed 2025-03-05 |
| 2022-09-30 | $9.06M 10-Q · filed 2023-11-07 | $17.01M derived: sum of 2 quarters · filed 2023-11-07 | $21.86M 10-Q · filed 2023-11-07 | $28.59M derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-06-30 | $7.95M 10-Q · filed 2023-08-01 | $12.80M 10-Q · filed 2023-08-01 | $19.53M derived: sum of 3 quarters · filed 2024-03-08 | $26.05M derived: sum of 4 quarters · filed 2024-03-08 |
| 2022-03-31 | $4.85M 10-Q · filed 2023-05-02 | $11.58M derived: sum of 2 quarters · filed 2024-03-08 | $18.11M derived: sum of 3 quarters · filed 2024-03-08 | $24.36M derived: sum of 4 quarters · filed 2024-03-08 |
| 2021-12-31 | $6.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $13.26M derived: sum of 2 quarters · filed 2024-03-08 | $19.51M derived: sum of 3 quarters · filed 2024-03-08 | $24.65M 10-K · filed 2024-03-08 |
| 2021-09-30 | $6.53M 10-Q · filed 2022-11-01 | $12.78M derived: sum of 2 quarters · filed 2022-11-01 | $17.91M 10-Q · filed 2022-11-01 | $21.72M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.25M 10-Q · filed 2022-08-04 | $11.39M 10-Q · filed 2022-08-04 | $15.20M derived: sum of 3 quarters · filed 2023-03-01 | $19.76M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $5.14M 10-Q · filed 2022-05-05 | $8.94M derived: sum of 2 quarters · filed 2023-03-01 | $13.51M derived: sum of 3 quarters · filed 2023-03-01 | $17.04M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.37M derived: sum of 2 quarters · filed 2023-03-01 | $11.90M derived: sum of 3 quarters · filed 2023-03-01 | $16.05M 10-K · filed 2023-03-01 |
| 2020-09-30 | $4.57M 10-Q · filed 2021-11-04 | $8.10M derived: sum of 2 quarters · filed 2021-11-04 | $12.24M 10-Q · filed 2021-11-04 | $16.74M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $3.53M 10-Q · filed 2021-08-05 | $7.67M 10-Q · filed 2021-08-05 | $12.18M derived: sum of 3 quarters · filed 2022-03-03 | $17.03M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $4.14M 10-Q · filed 2021-05-06 | $8.64M derived: sum of 2 quarters · filed 2022-03-03 | $13.49M derived: sum of 3 quarters · filed 2022-03-03 | $18.07M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $9.35M derived: sum of 2 quarters · filed 2022-03-03 | $13.93M derived: sum of 3 quarters · filed 2022-03-03 | $17.93M 10-K · filed 2022-03-03 |
| 2019-09-30 | $4.85M 10-Q · filed 2020-11-05 | $9.43M derived: sum of 2 quarters · filed 2020-11-05 | $13.43M 10-Q · filed 2020-11-05 | $17.48M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | $4.58M 10-Q · filed 2020-08-06 | $8.58M 10-Q · filed 2020-08-06 | $12.64M derived: sum of 3 quarters · filed 2021-03-11 | $16.48M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | $4.00M 10-Q · filed 2020-05-06 | $8.05M derived: sum of 2 quarters · filed 2021-03-11 | $11.90M derived: sum of 3 quarters · filed 2021-03-11 | $15.71M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $7.90M derived: sum of 2 quarters · filed 2021-03-11 | $11.70M derived: sum of 3 quarters · filed 2021-03-11 | $14.88M 10-K · filed 2021-03-11 |
| 2018-09-30 | $3.84M 10-Q · filed 2019-11-08 | $7.65M derived: sum of 2 quarters · filed 2019-11-08 | $10.82M 10-Q · filed 2019-11-08 | $13.67M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-06-30 | $3.81M 10-Q · filed 2019-08-13 | $6.98M 10-Q · filed 2019-08-13 | $9.83M derived: sum of 3 quarters · filed 2020-03-05 | $12.71M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-03-31 | $3.17M 10-Q · filed 2019-05-09 | $6.02M derived: sum of 2 quarters · filed 2020-03-05 | $8.91M derived: sum of 3 quarters · filed 2020-03-05 | |
| 2017-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $5.73M derived: sum of 2 quarters · filed 2020-03-05 | $11.17M 10-K · filed 2020-03-05 | |
| 2017-09-30 | $2.88M 10-Q · filed 2018-10-31 | $8.32M 10-Q · filed 2018-10-31 | ||
| 2016-12-31 | $10.93M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |